Explore chapters and articles related to this topic
Bacteria
Published in Julius P. Kreier, Infection, Resistance, and Immunity, 2022
Atypical pneumonias are caused by several very different bacteria including: Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia psittaci. Mycoplasma lack a cell wall and are not sensitive to penicillin, but can be treated with other antibiotics.
Managing Pain in the Presence of Autoimmune Disease
Published in Sahar Swidan, Matthew Bennett, Advanced Therapeutics in Pain Medicine, 2020
For a very long time, people have used colloidal silver to treat infections. Silver is a great antimicrobial. Colloidal silver, however, is not very powerful and has to be used in high doses. It can never be used for long durations as it can produce toxic levels that can actually turn people blue. This is not good. Silver preparations formulated like the pH structured silver solution, a nanosilver, are able to work well at low doses. Thus, people could use much more every day then we would ever need to use and use it for many decades and never come close to a toxic level. Typically, because mycoplasma likes to create pain issues and brain problems, the recommendation is to continue the nanosilver until the pain and brain issues are gone. If, after stopping the silver solution, the person starts to backslide, including feeling the pain returning, then restart the silver solution immediately. Use it for 2 more months and then try to come off it again. This can be repeated as often as necessary until the person feels fine without it. Then we know all the chronic infections are gone. Typically, any other infection will be gone by the time the mycoplasma has been cleared. Dosing often times starts at 4 ounces once a day (done as a swish and swallow for 1–2 minutes) for 4 days, then 2 ounces a day.
Orthopaedics and musculoskeletal system
Published in Jagdish M. Gupta, John Beveridge, MCQs in Paediatrics, 2020
Jagdish M. Gupta, John Beveridge
14.24. Erythema multiforme is due todrugs.herpes simplex infection.mycoplasma infection.vaccines.post-staphylococcal infection.
Association between the presence of Mycoplasma spp. and male infertility
Published in Journal of Obstetrics and Gynaecology, 2022
Sajad Babakhani, Marziyeh Eslami, Mohammad Javad Kazemi, Mohammad Sadegh Shirsalimian, Sajad Rajabi
The pathogenesis of Mycoplasma spp. is associated with the host immunity status.Immunity status is associated with genetic andinnate characteristics, environmental factors,underlying disorders and even stress. Hence, in survey of Mycoplasma infection rate in infertile men, the immunity status should be taken into consideration (Atkinson et al. 2008). One way toeliminate this factor is to match patientand control groups regarding their quality of immunity infuture investigations by performing immunologic assays to determine the immunity status of the patients. In addition, the rate of genital infections such as those caused by Mycoplasma spp. in a community is substantially associated with sexual behavior and having multiple sexual partners (Safavifar et al. 2015). Considering the Iranian culture and since our study was conducted on married men, the discrepancies in the prevalence of Mycoplasma infection in our study and reports from other countries are reasonable.
Stevens Johnson syndrome: A review of a vision and life-threatening mucocutaneous disease including histopathology with updates on pathogenesis and genetic risk factors
Published in Seminars in Ophthalmology, 2021
Vamsee K. Neerukonda, Anna M. Stagner
Unlike EM, only a minority of SJS cases are attributed to infection; these cases are usually in children and due to infection with Mycoplasma pneumonia.69–72 The mechanism of infection-induced SJS is less well understood. Mycoplasma pneumonia is known to primarily infect the ciliated respiratory epithelium of the lower respiratory tract and typically does not directly infect the skin,73,74 suggesting an indirect mechanism of action such as molecular mimicry.75 The pathogen may serve as a surface antigen resulting in antigen-antibody complexes that cross-react with keratinocytes or serum proteins, facilitating a mass influx of inflammatory mediators leading to cellular dysfunction and tissue destruction. The possibility of hematogenous spread may be supported by the presence of Mycoplasma pneumonia in bullae fluid and cerebrospinal fluid of affected individuals.76
A plethora of manifestations following a Mycoplasma pneumoniae infection: a case report
Published in Acta Clinica Belgica, 2020
Imke Matthys, Daniel Borsboom, Sophia Steyaert, Delphine Vervloet, Kristoff Cornelis, Erik Vanderstraeten, Sébastien Kindt, Pieter Dewint, Valerie Lambrecht, Peter Sinnaeve, Christophe Van Steenkiste
Mycoplasma pneumoniae is a small bacterium with a high prevalence worldwide. Infection is usually asymptomatic or presents only as an upper or lower respiratory tract infection. But M. pneumoniae is not merely a pulmonary infection, it can have many manifestations. An unexpected disease course can develop, even in young and otherwise healthy patients. These extrapulmonary manifestations are associated with a variety of possible life-threatening complications, involving multiple organ systems [1–4]. In this case report, a 27-year-old young man initially presented himself with a terminal ileitis and then developed a cholestatic hepatitis, bilateral anterior uveitis and multi-systemic vasculitis. This high state of inflammation even led to an ACS based on slow flow in coronary aneurysms and/or cardiac vasculitis. Diagnostic work-up showed M. pneumoniae infection to be the cause and the patient was successfully treated with azithromycin and high-dose corticosteroids (1 mg/kg/day).